A woman wearing a mask walks past an information banner on Middle East Respiratory Syndrome (MERS) at the entrance of Bamrasnaradura Infectious Diseases Institute in Nonthaburi province, on the outskirts of Bangkok, Thailand, June 19, 2015. REUTERS/Chaiwat Subprasom
LONDON (Reuters) - Anyone who goes down with flu in Europe this winter could be asked to enrol in a randomised clinical trial in which they will either be given a drug, which may or may not work, or standard advice to take bedrest and paracetamol.
Those who agree could be helping the world prepare for the next potentially deadly disease pandemic as well as helping scientists who are now desperate to plug gaps in knowledge left by previous missed opportunities.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
